Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
In the Clinic Episode 63: Knee Pain Part 1, Diagnosis
BS Medicine Episode 630: Vitamin B12 Deficiency: Monthly shots or daily pills?
BS Medicine Episode 629: Deprescribing Cholinesterase Inhibitors: Good or bad idea?
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk








Please provide any additional comments (optional).